Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Neuronal Intranuclear Inclusion Disease presenting as juvenile Parkinsonism.

Wiltshire KM, Dunham C, Reid S, Auer RN, Suchowersky O.

Can J Neurol Sci. 2010 Mar;37(2):213-8.

PMID:
20437931
2.

Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease.

Sone J, Tanaka F, Koike H, Inukai A, Katsuno M, Yoshida M, Watanabe H, Sobue G.

Neurology. 2011 Apr 19;76(16):1372-6. doi: 10.1212/WNL.0b013e3182166e13. Epub 2011 Mar 16.

PMID:
21411744
3.

Neuronal intranuclear inclusion disease and juvenile parkinsonism.

O'Sullivan JD, Hanagasi HA, Daniel SE, Tidswell P, Davies SW, Lees AJ.

Mov Disord. 2000 Sep;15(5):990-5.

PMID:
11009211
4.

Neuronal intranuclear inclusion disease: two cases of dopa-responsive juvenile parkinsonism with drug-induced dyskinesia.

Lai SC, Jung SM, Grattan-Smith P, Sugo E, Lin YW, Chen RS, Chen CC, Wu-Chou YH, Lang AE, Lu CS.

Mov Disord. 2010 Jul 15;25(9):1274-9. doi: 10.1002/mds.22876.

PMID:
20629123
5.

Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child.

McFadden K, Hamilton RL, Insalaco SJ, Lavine L, Al-Mateen M, Wang G, Wiley CA.

J Neuropathol Exp Neurol. 2005 Jun;64(6):545-52.

6.

NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture.

Pountney DL, Raftery MJ, Chegini F, Blumbergs PC, Gai WP.

Acta Neuropathol. 2008 Dec;116(6):603-14. doi: 10.1007/s00401-008-0437-4. Epub 2008 Oct 3.

PMID:
18836734
7.

Clinicopathological features of adult-onset neuronal intranuclear inclusion disease.

Sone J, Mori K, Inagaki T, Katsumata R, Takagi S, Yokoi S, Araki K, Kato T, Nakamura T, Koike H, Takashima H, Hashiguchi A, Kohno Y, Kurashige T, Kuriyama M, Takiyama Y, Tsuchiya M, Kitagawa N, Kawamoto M, Yoshimura H, Suto Y, Nakayasu H, Uehara N, Sugiyama H, Takahashi M, Kokubun N, Konno T, Katsuno M, Tanaka F, Iwasaki Y, Yoshida M, Sobue G.

Brain. 2016 Dec;139(Pt 12):3170-3186. Epub 2016 Oct 25.

8.

Neuronal intranuclear hyaline inclusion disease showing motor-sensory and autonomic neuropathy.

Sone J, Hishikawa N, Koike H, Hattori N, Hirayama M, Nagamatsu M, Yamamoto M, Tanaka F, Yoshida M, Hashizume Y, Imamura H, Yamada E, Sobue G.

Neurology. 2005 Nov 22;65(10):1538-43.

PMID:
16301479
9.

Inclusion-positive cell types in adult-onset intranuclear inclusion body disease: implications for clinical diagnosis.

Liu Y, Mimuro M, Yoshida M, Hashizume Y, Niwa H, Miyao S, Ujihira N, Akatsu H.

Acta Neuropathol. 2008 Dec;116(6):615-23. doi: 10.1007/s00401-008-0442-7. Epub 2008 Oct 16.

PMID:
18923837
10.

Neuronal intranuclear inclusion disease: report on a case originally diagnosed as dopa-responsive dystonia with Lewy bodies.

Paviour DC, Revesz T, Holton JL, Evans A, Olsson JE, Lees AJ.

Mov Disord. 2005 Oct;20(10):1345-9.

PMID:
15966005
11.

Hereditary neuronal intranuclear inclusion disease with autonomic failure and cerebellar degeneration.

Zannolli R, Gilman S, Rossi S, Volpi N, Bernini A, Galluzzi P, Galimberti D, Pucci L, D'Ambrosio A, Morgese G, Giannini F.

Arch Neurol. 2002 Aug;59(8):1319-26.

PMID:
12164731
12.

Neuronal intranuclear inclusion disease in a horse.

Pumarola M, Vidal E, Trens JM, SerafĂ­n A, Marquez M, Ferrer I.

Acta Neuropathol. 2005 Aug;110(2):191-5. Epub 2005 Jun 22.

PMID:
15971054
13.

Familial neuronal intranuclear inclusion disease with ubiquitin positive inclusions.

Kimber TE, Blumbergs PC, Rice JP, Hallpike JF, Edis R, Thompson PD, Suthers G.

J Neurol Sci. 1998 Sep 18;160(1):33-40. Review.

PMID:
9804114
14.

[Neuronal Intranuclear Inclusion Disease].

Sone J, Sobue G.

Brain Nerve. 2017 Jan;69(1):5-16. doi: 10.11477/mf.1416200628. Japanese.

PMID:
28126973
15.

SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease.

Pountney DL, Huang Y, Burns RJ, Haan E, Thompson PD, Blumbergs PC, Gai WP.

Exp Neurol. 2003 Nov;184(1):436-46.

PMID:
14637113
16.

Sporadic adult-onset neuronal intranuclear inclusion disease with the main presentation of repeated cerebellar ataxia: a case study.

Sakurai T, Harada S, Wakida K, Yoshida M, Nishida H.

Rinsho Shinkeigaku. 2016 Jun 22;56(6):439-43. doi: 10.5692/clinicalneurol.cn-000875. Epub 2016 May 14. Japanese.

PMID:
27181748
17.

Ubiquitin-related proteins in neuronal and glial intranuclear inclusions in intranuclear inclusion body disease.

Mori F, Tanji K, Odagiri S, Hattori M, Hoshikawa Y, Kono C, Yasui K, Yokoi S, Hasegawa Y, Kamitani T, Yoshida M, Wakabayashi K.

Pathol Int. 2012 Jun;62(6):407-11. doi: 10.1111/j.1440-1827.2012.02812.x. Epub 2012 Mar 16.

PMID:
22612509
18.

[Neuronal intranuclear hyaline inclusion disease (NIHID): an update].

Takahashi-Fujigasaki J.

Brain Nerve. 2015 Feb;67(2):199-204. doi: 10.11477/mf.1416200112. Review. Japanese.

PMID:
25681365
19.

Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions.

Woulfe J, Kertesz A, Munoz DG.

Acta Neuropathol. 2001 Jul;102(1):94-102.

PMID:
11547957
20.

Juvenile levodopa-responsive Parkinsonism with early orobuccolingual dyskinesias and cognitive impairment.

Espay AJ, Paviour DC, O'Sullivan JD, Schmidt RE, Revilla FJ, Metman LV.

Mov Disord. 2010 Sep 15;25(12):1860-7. doi: 10.1002/mds.23194.

PMID:
20669183

Supplemental Content

Support Center